Social Responsibility

Ovarian Cancer Australia welcomes over $16 million to fast track research

Health Industry Hub | May 13, 2020 |
[Total: 0    Average: 0/5]

Ovarian Cancer Australia welcomed the Federal Government’s announcement of a groundbreaking $16.2 million in funding for ovarian cancer research.

The announcement on World Ovarian Cancer Day supports $16.2 millon to fast track eight ovarian cancer research projects. These projects align all of the areas outlined in the National Action Plan led by Ovarian Cancer Australia.

Ovarian Cancer Australia CEO Jane Hill welcomed the news on behalf of women living with ovarian cancer and thanked the Government for their investment.

“These eight projects will support research in our key priority areas including an improved understanding of risk factors, early diagnosis and treatment, best practice models for clinical management, and repurposing drugs for ovarian cancer that is treatment-resistant.”

“We welcome this news on behalf of every woman impacted by ovarian cancer. In funding this research, the Government has recognised the desperate need to step in and make a difference to the trajectory of this devastating disease.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

There are 300,000 women living with ovarian cancer around the world. Every year in Australia, more than 1,500 women are diagnosed with ovarian cancer and more than 1,000 will die. Only 46% of women diagnosed with ovarian cancer will survive five years post diagnosis. This is well below the average for all cancers in Australia. Approximately 70% of women diagnosed with ovarian cancer experience a recurrence.

“Women living with an ovarian cancer diagnosis feel isolated and vulnerable. It can be a lonely disease and now these women are dealing with the higher levels of uncertainty in a world that has dramatically changed.

“Our support nurses are receiving double the calls to our Helpline during this time. The announcement gives women living with ovarian cancer more than hope – that changing the dire outcomes of this disease is indeed a national priority,” she said.

The National Action Plan is owned and authored by the sector, as well as consumers and recognises that all parts of the sector are needed to collaborate to drive change, to improve survival rates and reduce the incidence of ovarian cancer.

The outcomes of this research will help us understand the underlying factors that contribute to the development and progression of ovarian cancer, and how best to manage and treat this devastating disease.

Ovarian cancer survivor, and mother of two boys, Ann-Maree Mulders, also welcomed the news. “When I was diagnosed with ovarian cancer I learnt that the odds are so bad so living through it feels like a miracle. It’s just such a devastating disease. 54% of women diagnosed are dead within five years. With those stats ringing in your ears, survival feels like a hopeless ambition.

“Thank you from the bottom of my heart, and the heart of every woman who will hear this dreaded diagnosis today, tomorrow and in the future. Finally there is some hope for us,” she said.

The 2020 National Action Plan is due to be released in June 2020.

You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Growth of the surgical robotics market in Australia

Growth of the surgical robotics market in Australia

Health Industry Hub | November 25, 2020 |

In Australia, the penetration of surgical robots has been limited to a range of products that are manufactured internationally Australia […]

More


News & Trends - Biotechnology

Biotech News - Cutting edge technology paving the way for new treatments

Cutting edge technology paving the way for new treatments

Health Industry Hub | November 25, 2020 |

Biotech News: Researchers used cutting edge technology to bioprint human kidneys, paving the way for new treatments for kidney failure […]

More


News & Trends - Pharmaceuticals

Pharma News - AstraZeneca gears up for COVID vaccine regulatory submission

AstraZeneca gears up for COVID vaccine regulatory submission

Health Industry Hub | November 25, 2020 |

Pharma News: Following the positive high-level results from two of the phase II/III Oxford University-led clinical trials, AstraZeneca is seeking […]

More


News & Trends - Medical Technology

MedTech News - RACS and GESA sign agreement to enhance colonoscopy services

RACS and GESA sign agreement to enhance colonoscopy services

Health Industry Hub | November 25, 2020 |

MedTech News: The Gastroenterological Society of Australia (GESA) and the Royal Australasian College of Surgeons (RACS) announced they have signed […]

More